In the autumn of 2018, a Queen biopic that had lost its original director mid-shoot and drawn lukewarm reviews became one of the most profitable studio films of its decade. Bohemian Rhapsody grossed more than 900 million dollars worldwide against a production budget of roughly 52 million, won four Academy Awards including Best Actor for Rami Malek, and sent Queen’s catalogue surging up the streaming charts. Hollywood noticed. The music biopic, a genre as old as The Jolson Story, has since become one of the most reliable financial templates in mainstream cinema.
A template with unusual margins
The economics rest on a simple asymmetry: biopics cost like mid-budget dramas and can earn like franchise films. Straight Outta Compton turned a 28 million dollar budget into more than 200 million worldwide in 2015. Rocketman took around 195 million against roughly 40 million in 2019. Baz Luhrmann’s Elvis reached 288 million in 2022, and Bob Marley: One Love earned about 180 million in early 2024 on a 70 million budget, dominating a quiet release window. The audience arrives pre-sold, marketing leans on decades of existing affection, and the soundtrack is a proven catalogue rather than a gamble. No superhero-scale budget is required because the special effect is the songbook.
The catalogue effect
The theatrical gross is only the visible half of the return. After Bohemian Rhapsody, streams of Queen’s music multiplied, and the title track was announced in December 2018 as the most-streamed song recorded in the twentieth century. Elton John’s catalogue enjoyed a similar lift around Rocketman, and Elvis Presley’s around Luhrmann’s film. For rights holders, a biopic functions as a two-hour, globally distributed advertisement for a music catalogue, arriving precisely in the era when catalogues are traded as high-value assets. This is why estates and publishers increasingly initiate projects rather than merely licensing to them.
The estate bargain
That involvement carries a creative price that has become the genre’s central criticism. Because the films depend on music rights, estates and surviving band members hold effective veto power, and the results tend toward authorised versions of a life. Bohemian Rhapsody was widely criticised for softening Freddie Mercury’s story even as it broke records. The bargain does not always pay either: I Wanna Dance with Somebody, the 2022 Whitney Houston film made with estate cooperation, managed only around 60 million dollars worldwide, a reminder that reverence alone does not sell tickets. James Mangold’s Bob Dylan film A Complete Unknown, released in December 2024 with its subject’s blessing and eight Academy Award nominations, showed the more artful version of the same arrangement, cooperation without hagiography.
Awards as the second revenue stream
The genre’s other structural advantage is institutional. Transformative portrayals of real musicians are among the most reliably rewarded performances in Hollywood: Jamie Foxx won Best Actor for Ray in 2005, Reese Witherspoon for Walk the Line in 2006, Renée Zellweger for Judy in 2020 and Malek for Bohemian Rhapsody in 2019, while Austin Butler’s Elvis earned a nomination and a long promotional afterlife. An awards run extends a film’s theatrical window, lifts its streaming value and feeds the annual speculation economy around the Oscars, where biopic leads are perennial favourites in entertainment betting markets long before nominations are announced. Studios budget for the campaign because the campaign is part of the product.
Where the formula strains
The risk now is saturation. Projects on Michael Jackson, Bruce Springsteen and the Beatles, the latter planned by Sam Mendes as four separate films, are all in motion, and each new entry tests whether audiences will keep paying for the same narrative arc of rise, excess and redemption with different songs. The genre has absorbed flops before and survived on its fundamentals: modest budgets, built-in audiences, catalogue upside and awards potential. As long as those four levers hold, the music biopic will remain what it became after 2018, the closest thing risk-averse Hollywood has to a house edge.